Internal Server Error

MetaScan Diagnostics - About the company

MetaScan Diagnostics is an unfunded company based in Hartford (United States), founded in 2013 by Peter Jacobson. It operates as a Provider of diagnostic solutions for the early detection of cancer. MetaScan Diagnostics has not raised any funding yet. The company has 516 active competitors, including 153 funded and 116 that have exited. Its top competitors include companies like Guardant Health, Natera and Myriad Genetics.

Company Details

Provider of diagnostic solutions for the early detection of cancer. The platform technology Hierarchial Diagnostics analyzes blood serum samples for metabolic disease signatures using ultra-high resolution mass spectrometry. Its flagship product MetaScan is a non-invasive blood-based metabolomics assay that can be used for early detection of sixteen types of cancer, including breast, colorectal, prostate, lung, and ovarian cancers.
Email ID
*****@metascandiagnostics.com
Key Metrics
Founded Year
2013
Location
Hartford, United States
Stage
Unfunded
Ranked
Similar Companies
Sign up to download MetaScan Diagnostics' company profile

MetaScan Diagnostics's funding and investors

MetaScan Diagnostics has not raised any funding rounds yet.

MetaScan Diagnostics' founders and board of directors

Founder? Claim Profile
The founders of MetaScan Diagnostics is Peter Jacobson.
Here are the details of MetaScan Diagnostics' key team members:
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

MetaScan Diagnostics's Competitors and alternates

Top competitors of MetaScan Diagnostics include Guardant Health, Natera and Myriad Genetics. Here is the list of Top 10 competitors of MetaScan Diagnostics, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Guardant Health
Guardant Health
2012, Redwood City (United States), Public
Developer of digital sequencing technology for cancer detection
$557M
79/100
2nd
Logo for Natera
Natera
2004, Redwood City (United States), Public
Developer of cell-free DNA testing for oncology, women’s health, and organ health
$152M
77/100
3rd
Developer of molecular diagnostics and personalized medicine for cancer
-
72/100
4th
Logo for Foundation Medicine
Foundation Medicine
2010, Cambridge (United States), Acquired
Provider of genomics-based diagnostics test for cancer
$96.5M
71/100
5th
Logo for Caris Life Sciences
Caris Life Sciences
1996, Irving (United States), Public
Developer of panomic disease profiling technologies for cancer precision medicine
$1.23B
71/100
6th
Logo for Exact Sciences
Exact Sciences
1995, Madison (United States), Acquired
Provider of non-invasive molecular diagnostic testing solutions for cancer
-
71/100
7th
Logo for Prenetics
Prenetics
2009, Hong Kong (China), Public
Online platform for genetic and diagnostic health testing that helps identify health risks
$67.6M
70/100
8th
Logo for BillionToOne
BillionToOne
2015, San Francisco (United States), Public
Provider of cell-free cancer liquid biopsy test
$389M
69/100
9th
Logo for Delfi Diagnostics
Delfi Diagnostics
2019, Baltimore (United States), Series B
Provider of DNA sequencing for cancer detection
$332M
68/100
10th
Logo for Foresight Diagnostics
Foresight Diagnostics
2020, Aurora (United States), Acquired
Developer of minimally-invasive liquid biopsy test for the detection of cancer
$104M
66/100
431st
Logo for MetaScan Diagnostics
MetaScan Diagnostics
2013, Hartford (United States), Unfunded
Provider of diagnostic solutions for the early detection of cancer
-
-
24/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on MetaScan Diagnostics's competitors? Click here to see the top ones

MetaScan Diagnostics's Investments and acquisitions

MetaScan Diagnostics has made no investments or acquisitions yet.

FAQs about MetaScan Diagnostics

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford